{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:24:11Z","timestamp":1782779051662,"version":"3.54.5"},"reference-count":45,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[2011,6,7]]},"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The prevalence of end-stage renal disease (ESRD) is increasing worldwide. Although increased levels of coeliac disease (CD) autoantibodies are often seen in renal disease, the importance of biopsy-verified CD for the risk of future ESRD is unclear. The aim of this study was therefore to investigate the risk of future ESRD in individuals with CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a population-based prospective cohort study. 29\u2008050 individuals with CD (Marsh III) were identified through small-intestinal biopsy reports obtained between July 1969 and February 2008 in Sweden's 28 pathology departments. ESRD was defined as the need for renal dialysis or renal transplant in accordance with the international classification of disease and procedure codes in Swedish patient registers. Using Cox regression, the risk of ESRD in individuals with CD compared with age- and sex-matched reference individuals was estimated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 90 individuals with CD developed ESRD (expected count 31). This corresponded to a HR for ESRD of 2.87 (95% CI 2.22 to 3.71, p&lt;0.001). Adjusting for diabetes mellitus had only a marginal effect on the risk estimate (HR 2.52, 95% CI 1.92 to 3.31). Excluding individuals with any urinary\/renal disorder before study entry, the HR for ESRD in CD was 2.47 (95% CI 1.80 to 3.40). When restricting the outcome measure to ESRD confirmed by independent data from the Swedish Renal Registry (SRR), the risk estimate increased to 3.20 (95% CI 2.39 to 4.28).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicates that individuals with biopsy-verified CD suffer increased risk of subsequent ESRD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2011-300134","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T22:39:06Z","timestamp":1312411146000},"page":"64-68","source":"Crossref","is-referenced-by-count":36,"title":["Increased risk of end-stage renal disease in individuals with coeliac disease"],"prefix":"10.1136","volume":"61","author":[{"given":"Adina","family":"Welander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-G\u00f6ran","family":"Pr\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fored","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2011,8,3]]},"reference":[{"key":"2025120521330493000_61.1.64.1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3283365263"},{"key":"2025120521330493000_61.1.64.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021687"},{"key":"2025120521330493000_61.1.64.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.014"},{"key":"2025120521330493000_61.1.64.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071600"},{"key":"2025120521330493000_61.1.64.5","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36585"},{"key":"2025120521330493000_61.1.64.6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.9.1215"},{"key":"2025120521330493000_61.1.64.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0960"},{"key":"2025120521330493000_61.1.64.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-2-200407200-00007"},{"key":"2025120521330493000_61.1.64.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000067420.83632.C1"},{"key":"2025120521330493000_61.1.64.10","unstructured":"Swedish Renal Registry. Active uraemia care in Sweden 1991\u20132009, 2010. http:\/\/www.medscinet.net\/snr\/rapporterdocs\/AKTIV%20UREMIV\u00c5RD%20I%20SVERIGE%201991%20-%202009.pdf (accessed 1 May 2011)."},{"key":"2025120521330493000_61.1.64.11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2249.1992.tb07947.x","article-title":"Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis","volume":"90","author":"Rostoker","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2025120521330493000_61.1.64.12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.3.513"},{"key":"2025120521330493000_61.1.64.13","doi-asserted-by":"publisher","DOI":"10.1159\/000169050"},{"key":"2025120521330493000_61.1.64.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04045.x"},{"key":"2025120521330493000_61.1.64.15","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33387"},{"key":"2025120521330493000_61.1.64.16","doi-asserted-by":"publisher","DOI":"10.1159\/000013497"},{"key":"2025120521330493000_61.1.64.17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/ndt\/8.11.1193","article-title":"Low-antigen-content diet in the treatment of patients with IgA nephropathy","volume":"8","author":"Ferri","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"2025120521330493000_61.1.64.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06025.x"},{"key":"2025120521330493000_61.1.64.19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl117"},{"key":"2025120521330493000_61.1.64.20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.13.1566"},{"key":"2025120521330493000_61.1.64.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1320"},{"key":"2025120521330493000_61.1.64.22","doi-asserted-by":"publisher","DOI":"10.1080\/00365590410033380"},{"key":"2025120521330493000_61.1.64.23","doi-asserted-by":"crossref","unstructured":"Mogensen CE Christensen CK Vittinghus E . The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32 Suppl 2:64\u201378.","DOI":"10.2337\/diab.32.2.S64"},{"key":"2025120521330493000_61.1.64.24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.345"},{"key":"2025120521330493000_61.1.64.25","unstructured":"Johannesson I . The Total Population Register of Statistics Sweden: New Possibilities and Better Quality. \u00d6rebro: Statistics Sweden, 2002."},{"key":"2025120521330493000_61.1.64.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9350-y"},{"key":"2025120521330493000_61.1.64.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-9-19"},{"key":"2025120521330493000_61.1.64.28","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.1999.540207.x"},{"key":"2025120521330493000_61.1.64.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(00)00366-1"},{"key":"2025120521330493000_61.1.64.30","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706008385"},{"key":"2025120521330493000_61.1.64.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.7.668"},{"key":"2025120521330493000_61.1.64.32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.60"},{"key":"2025120521330493000_61.1.64.33","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200309000-00009"},{"key":"2025120521330493000_61.1.64.34","doi-asserted-by":"publisher","DOI":"10.1159\/000027133"},{"key":"2025120521330493000_61.1.64.35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diacare.25.5.859","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study","volume":"25","author":"Rossing","year":"2002","journal-title":"Diabetes Care"},{"key":"2025120521330493000_61.1.64.36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.007"},{"key":"2025120521330493000_61.1.64.37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00868251"},{"key":"2025120521330493000_61.1.64.38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00005792-199403000-00002","article-title":"IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature","volume":"73","author":"Ibels","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"2025120521330493000_61.1.64.39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.1996.67","article-title":"HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations","volume":"49","author":"Fennessy","year":"1996","journal-title":"Kidney Int"},{"key":"2025120521330493000_61.1.64.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020109"},{"key":"2025120521330493000_61.1.64.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6590.78"},{"key":"2025120521330493000_61.1.64.42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.4.476"},{"key":"2025120521330493000_61.1.64.43","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2007.08.003"},{"key":"2025120521330493000_61.1.64.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2007.01.002"},{"key":"2025120521330493000_61.1.64.45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002273"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2011-300134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:33:17Z","timestamp":1764999197000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2011-300134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,12,1]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1136\/gutjnl-2011-300134"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2011-300134","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,3]]}}}